Literature DB >> 30701197

Transglutaminase in Receptor and Neurotransmitter-Regulated Functions.

Nancy A Muma1.   

Abstract

Transglutaminases (TGs) and especially TG2 play important roles in neurotransmitter and receptor signaling pathways. Three different mechanisms by which TG2 interacts with neurotransmitter and receptor signaling systems will be discussed in this review. The first way in which TG2 interacts with receptor signaling is via its function as a guanine nucleotide binding protein (G-protein) coupling to G-protein coupled receptors (GPCRs) to activate down-stream signaling pathways. TG2 can exist in a least two conformations, a closed GTP-bound conformation and an open calcium-bound conformation. In the closed GTP-bound conformation, TG2 is capable of functioning as a G-protein for GPCRs. In the open calcium-bound conformation, TG2 catalyzes a transamidation reaction cross-linking proteins or catalyzing the covalent binding of a mono- or polyamine to a protein. The second mechanism is regulation of the transamidation reaction catalyzed by TG2 via receptor stimulation which can increase local calcium concentrations and thereby increase transamidation reactions. The third way in which TG2 plays a role in neurotransmitter and receptor signaling systems is via its use of monoamine neurotransmitters as a substrate. Monoamine neurotransmitters including serotonin can be substrates for transamidation to a protein often a small G-protein (also known as a small GTPase) resulting in activation of the small G-protein. The transamidation of a monoamine neurotransmitter or serotonin has been designated as monoaminylation or more specifically serotonylation, respectively. Other proteins are also targets for monoaminylation such as fibronectin and cytoskeletal proteins. These receptor and neurotransmitter-regulated reactions by TG2 play roles in physiological and key pathophysiological processes.

Entities:  

Keywords:  Gαh; monoaminylation; serotonylation; transamidation; transglutaminase

Year:  2018        PMID: 30701197      PMCID: PMC6349232          DOI: 10.20900/mo.20180012

Source DB:  PubMed          Journal:  Med One        ISSN: 2397-9119


  66 in total

1.  Deamidation of RhoA glutamine 63 by the Escherichia coli CNF1 toxin requires a short sequence of the GTPase switch 2 domain.

Authors:  G Flatau; L Landraud; P Boquet; M Bruzzone; P Munro
Journal:  Biochem Biophys Res Commun       Date:  2000-01-19       Impact factor: 3.575

2.  Identification of the C-terminal part of Bordetella dermonecrotic toxin as a transglutaminase for rho GTPases.

Authors:  G Schmidt; U M Goehring; J Schirmer; M Lerm; K Aktories
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

3.  In vivo modifications of small GTPase Rac and Cdc42 by Bordetella dermonecrotic toxin.

Authors:  Minako Masuda; Masayoshi Minami; Hiroaki Shime; Takeshi Matsuzawa; Yasuhiko Horiguchi
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface.

Authors:  George L Dale; Paul Friese; Peter Batar; Stephen F Hamilton; Guy L Reed; Kenneth W Jackson; Kenneth J Clemetson; Lorenzo Alberio
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

5.  Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II.

Authors:  J F Feng; M Readon; S P Yadav; M J Im
Journal:  Biochemistry       Date:  1999-08-17       Impact factor: 3.162

6.  Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells.

Authors:  Ugra S Singh; Jing Pan; Yu-Lin Kao; Suchitra Joshi; Keri L Young; Kenneth M Baker
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

7.  Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh.

Authors:  R Vezza; A Habib; G A FitzGerald
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

8.  Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z.

Authors:  P Grenard; M K Bates; D Aeschlimann
Journal:  J Biol Chem       Date:  2001-06-04       Impact factor: 5.157

Review 9.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

10.  Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient.

Authors:  Francesca Bernassola; Massimo Federici; Marco Corazzari; Alessandro Terrinoni; Marta L Hribal; Vincenzo De Laurenzi; Marco Ranalli; Ornella Massa; Giorgio Sesti; W H Irwin McLean; Gennaro Citro; Fabrizio Barbetti; Gerry Melino
Journal:  FASEB J       Date:  2002-09       Impact factor: 5.191

View more
  2 in total

1.  Transglutaminase 2 Has Metabolic and Vascular Regulatory Functions Revealed by In Vivo Activation of Alpha1-Adrenergic Receptor.

Authors:  Kinga Lénárt; Attila Pap; Róbert Pórszász; Anna V Oláh; László Fésüs; András Mádi
Journal:  Int J Mol Sci       Date:  2020-05-29       Impact factor: 5.923

2.  Serotonin stimulated parathyroid hormone related protein induction in the mammary epithelia by transglutaminase-dependent serotonylation.

Authors:  Celeste M Sheftel; Laura L Hernandez
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.